"I was driving home listening to the radio when something suddenly changed. By the time I pulled into my driveway, I realized ...
Lynch tells USA TODAY her dad strongly resisted hearing aids. At the time, she says, the devices were large and bulky − ...
The Onion’s plan to take over the Infowars platforms that Alex Jones built into a bullhorn of conspiracy theories and turn ...
A Texas judge is set to consider Thursday whether to approve the satirical news outlet’s proposed takeover, though Jones has ...
The agency's decision is based on results from a clinical trial in which the treatment improved hearing in 80 percent of the ...
Regeneron will make its newly approved gene therapy Otarmeni for a rare, genetic form of hearing loss available for free in the U.S. The company hasn't decided how it will price the therapy overseas, ...
A new therapy for genetic hearing loss has just been approved by the Food and Drug Administration (FDA). The treatment, Otarmeni (lunsotogene parvec-cwha), is the first-ever dual adeno-associated ...
Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Kelly ...
US health officials on Thursday greenlit a first-of-its-kind gene therapy to treat a rare form of hereditary hearing loss, a breakthrough that could pave the way for other such hearing impairment ...
Children born deaf because of a rare condition can now take a drug to restore their hearing after a gene therapy was approved in the U.S., ushering in a new era for the treatment of an inherited form ...
The Food and Drug Administration on Thursday approved Regeneron’s Otarmeni, the first gene therapy for genetic hearing loss. Subscribe to read this story ad-free Get unlimited access to ad-free ...
Regeneron agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump. The biotech company will also offer the first hearing-loss gene therapy for free to ...